At this time, posts about Bukwang Pharmaceutical are rapidly increasing on portals and securities communities. Today, foreigners have tentatively sold a net 55,624 shares of Bukwang Pharmaceutical, while institutions have sold a net 10,000 shares. Bukwang Pharmaceutical is known as a manufacturer of pharmaceuticals and quasi-drugs (such as toothpaste).

As of 11:30 AM on the 26th, Bukwang Pharmaceutical's stock price is 26,250 KRW, down 0.19% from the previous day, with a trading volume of 1,770,876 shares, which is 59.0% of the 5-day average trading volume. On May 18th, Bukwang Pharmaceutical was a market issue with the theme "Strong due to expectations for COVID-19 clinical trials."

In addition to Bukwang Pharmaceutical, posts by investors are also rapidly increasing for AfreecaTV (067160), RaonSecure (042510), and Antrogen (065660).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing